The Ritedose Corporation The Ritedose Corporation

  • HOME
  • ABOUT US
  • MANUFACTURING
  • QUALITY
  • DEVELOPMENT
  • 503B CONTACT US
  • News
  • CONTACT
Team
    The Ritedose Corporation > Team

Jody Chastain

July 19, 2015

Continue reading

Uday Doshi

March 3, 2020

Continue reading

Steven Franchak

February 11, 2019

Continue reading

Angie Koen

July 19, 2015

Continue reading

Mohammad Sadeghi

July 19, 2015

Continue reading

Shawn Collins

September 26, 2018

Continue reading

Ken Weems

March 3, 2020

Continue reading

Julia Bales

March 3, 2020

Continue reading

Carol Morgan

February 11, 2019

Continue reading

Lori Wedemyer

December 16, 2016

Continue reading
  • 1
  • 2

Recent Posts

  • Ritedose Launches New 503B, Single-Dose Syringe Medications for Hospitals: Rocuronium Bromide Injection (50 mg/5mL) and Rocuronium Bromide Injection (100 mg/10mL)
  • The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser
    SuredoseRx™ to launch in first quarter
  • Ritedose Pharmaceuticals Launches Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 ml
  • Novo Holdings to acquire Ritedose:
    Novo Holdings A/S (“Novo Holdings”) today announced that it has agreed to acquire Ritedose from AGIC Capital and Humanwell.
  • Ritedose Pharmaceuticals Launches Budesonide Inhalation Suspension (0.5 mg/2 ml)

Recent Comments

    Archives

    • February 2022
    • January 2022
    • December 2021
    • September 2021
    • August 2021
    • May 2021
    • April 2021
    • March 2021
    • November 2020
    • August 2020
    • March 2020

    Categories

    • In the News
    • Press Releases
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Recent News

    • Ritedose Launches New 503B, Single-Dose Syringe Medications for Hospitals: Rocuronium Bromide Injection (50 mg/5mL) and Rocuronium Bromide Injection (100 mg/10mL) Posted on 28th February, 2022
    • The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser
      SuredoseRx™ to launch in first quarter
      Posted on 18th January, 2022
    • Ritedose Pharmaceuticals Launches Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 ml Posted on 5th January, 2022

    Post Categories

    • In the News (11)
    • Press Releases (10)
    • Uncategorized (8)

    Search Posts

    The Ritedose Corporation
    1 Technology Circle
    Columbia, SC 29203
    (803) 806-3300

    Copyright © 2022 The Ritedose Corporation. All rights reserved.

    Your ticket for the: Jody Chastain

    Title

    Jody Chastain

    USD

    - - -